Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is fibrolamellar carcinoma?
Fibrolamellar carcinoma (FLC) is an unusual form of liver cancer that mostly affects adolescents and young adults — typically people in their teens to thirties — who do not have the cirrhosis, hepatitis, or alcohol-related liver damage seen with ordinary liver cancer. Under the microscope the tumor cells are separated by bands of fibrous tissue arranged in layers ('lamellae'), which gives the disease its name. Almost every case is driven by a single, distinctive genetic event: a fusion of two genes called DNAJB1 and PRKACA that switches on abnormal cell growth. Because symptoms (vague belly pain, fullness, weight loss) are easy to dismiss in a healthy young person, FLC is often found late, after it has grown large or spread to nearby lymph nodes. Complete surgical removal offers the best chance of long-term survival.
The main types
Doctors group fibrolamellar carcinoma by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Classic fibrolamellar carcinoma | The standard form: large cells in fibrous bands, arising in an otherwise healthy liver, almost always carrying the DNAJB1-PRKACA fusion. |
| Mixed fibrolamellar / conventional | A rarer overlap in which the tumor has features of both fibrolamellar and ordinary liver cancer; managed by liver-cancer experts. |
Staging, in plain terms
Fibrolamellar carcinoma is staged with the same TNM system as other liver cancers — based on tumor size and number (T), lymph node spread (N), and distant spread (M) — but in practice the most important question is whether the tumor can be completely removed. Lymph node involvement is more common in FLC than in ordinary liver cancer and lowers the odds of cure.
| Liver-cancer TNM + resectability | What it generally means |
|---|---|
| Localized, resectable | The tumor is confined to the liver and can be removed with surgery. This offers the best chance of long-term survival. |
| Locally advanced / node-positive | The tumor involves nearby lymph nodes or major structures, making complete removal harder and raising the chance of recurrence. |
| Metastatic | Cancer has spread beyond the liver, such as to the lungs or distant lymph nodes. Treatment focuses on control and clinical trials. |
The standard of care
Fibrolamellar Carcinoma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Surgery (the cornerstone)
Removing the tumor — by taking out the affected part of the liver, often along with nearby lymph nodes — is the only treatment shown to cure FLC. Because the rest of the liver is healthy, surgeons can often remove a large portion safely.
Repeat surgery for recurrence
FLC frequently comes back, but it tends to grow slowly. Removing recurrences or isolated spread with further surgery can extend life for years.
Systemic therapy for advanced disease
When surgery is not possible, chemotherapy and targeted or immune-based therapies are used; responses are variable, so enrollment in a clinical trial is encouraged.
Radiation — supportive role
FLC is not primarily treated with radiation, but focused radiation (including SBRT) can control tumors that cannot be removed or relieve symptoms from spread.
How radiation treatment works
Radiation damages the DNA inside cancer cells so they can no longer divide. In fibrolamellar carcinoma, surgery does the curative work, but radiation has a valuable supporting role: highly focused techniques such as SBRT can wipe out a tumor that cannot be removed or an isolated spot of spread, while protecting the healthy liver these young patients depend on. Modern liver radiation accounts for the way the liver moves with each breath, so the beam stays locked on the target. It is painless and leaves no radioactivity behind.
The main ways radiation is delivered for fibrolamellar carcinoma:
Stereotactic body radiation therapy (SBRT)
Delivers a few high, pinpoint doses to a liver tumor or an isolated site of spread, controlling disease that cannot be surgically removed while sparing the surrounding healthy liver.
Conformal / IGRT photon radiation
Image-guided beams shape the dose around the tumor and adjust for breathing motion, useful for larger or awkwardly placed tumors or for easing symptoms.
Proton beam therapy
Protons stop after reaching the tumor, helpful for preserving as much healthy liver as possible in young patients who may need their liver for decades.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
DNAJB1-PRKACA peptide vaccine trial (NCT06789198): A vaccine that trains the immune system against the DNAJB1-PRKACA fusion protein opened to patients in 2025, part of a new wave of therapies aimed directly at the genetic event that drives nearly all fibrolamellar carcinoma.[1]
ClinicalTrials.gov NCT06789198
Fusion-kinase vaccine plus immunotherapy (NCT04248569): A study combining a DNAJB1-PRKACA peptide vaccine with the immune checkpoint drugs nivolumab and ipilimumab is testing whether targeting the fusion alongside immunotherapy can control advanced disease.[2]
ClinicalTrials.gov NCT04248569
Contemporary review of FLC management: A 2025 review reaffirmed complete surgical resection as the primary curative treatment for localized disease — noting high recurrence rates — while highlighting emerging molecular and immune therapies for advanced cases.[3]
PubMed 41178855 (2025)
Common questions
Why did I get liver cancer when my liver is healthy? Fibrolamellar carcinoma is different from ordinary liver cancer. It is not caused by cirrhosis, hepatitis, or alcohol. Instead it is driven by a specific gene fusion (DNAJB1-PRKACA) that arises in the tumor itself — it is not something you did, and in most people it is not inherited.
Is surgery really the main treatment? Yes. Completely removing the tumor offers the only proven chance of cure, and because the rest of your liver is healthy, surgeons can often remove a large amount safely. If the cancer returns, further surgery is frequently possible because FLC tends to grow slowly.
Does radiation help? Radiation is not the main treatment, but focused techniques like SBRT can control tumors that cannot be removed or treat an isolated area of spread, while sparing your healthy liver. Your team will weigh it alongside surgery, systemic therapy, and clinical trials.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.
- ClinicalTrials.gov NCT06789198 (no indexed identifier — see your care team) ↩
- ClinicalTrials.gov NCT04248569 (no indexed identifier — see your care team) ↩
- PubMed 41178855 (2025) (no indexed identifier — see your care team) ↩